Post-Traumatic Stress Disorder Clinical Trial
— EYIPTSDOfficial title:
Evaluation of a Yoga Intervention for Post-Traumatic Stress Disorder
Verified date | March 2013 |
Source | Brigham and Women's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The main objective of this preliminary randomized controlled clinical trial is to establish efficacy and feasibility of a yoga-based treatment for PTSD in military veterans as compared to a delayed yoga treatment (waitlist control) group. Secondary objectives are to evaluate PTSD characteristics that may also be improved with the treatment and acceptability and compliance with the treatment.
Status | Completed |
Enrollment | 108 |
Est. completion date | May 2012 |
Est. primary completion date | May 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Male and female military veterans and active duty military personnel aged 18 and older - A DSM IV diagnosis of post-traumatic stress disorder - Potential subjects on medications are eligible to participate in the study - Potential subjects who receive ongoing medical or psychological treatment are eligible to participate in this study as long as these treatments do not include more than one hour weekly of relaxation and mind-body based stress reduction strategies (strategies directly related to meditation and yoga) - Potential subjects are eligible to participate in this study if they have sufficient mental and physical ability to fully participate in the parameters of the study. Subjects must be able to understand and comply with instructions in the group yoga sessions and home practice, complete questionnaires, participate in clinical interviews, and take part in all data collection activities. Subjects with severe mental or physical concerns that may prevent them from understanding and/or complying with the treatment will be excluded. For example, potential subjects confined to wheelchairs will not be eligible, although subjects with artificial limbs who are able to reasonably participate in the intervention may be deemed eligible. These determinations will be made during discussions with potential subjects on a case by case basis during the screening process Exclusion Criteria: - Potential subjects are ineligible if pregnant and in their third trimester. - Potential subjects are ineligible if they are confined to a wheel chair. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Brigham and Women's Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Brigham and Women's Hospital | United States Department of Defense |
United States,
Creamer M, Burgess P, McFarlane AC. Post-traumatic stress disorder: findings from the Australian National Survey of Mental Health and Well-being. Psychol Med. 2001 Oct;31(7):1237-47. — View Citation
Hoge CW, Auchterlonie JL, Milliken CS. Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan. JAMA. 2006 Mar 1;295(9):1023-32. — View Citation
Morse DR, Cohen L, Furst ML, Martin JS. A physiological evaluation of the yoga concept of respiratory control of autonomic nervous system activity. Int J Psychosom. 1984;31(1):3-19. — View Citation
Seligman MEP. Learned Optimism, 2nd Edition ed. New York, NY: Pocket Books; 1998.
van der Kolk BA, Roth S, Pelcovitz D, Sunday S, Spinazzola J. Disorders of extreme stress: The empirical foundation of a complex adaptation to trauma. J Trauma Stress. 2005 Oct;18(5):389-99. — View Citation
van der Kolk BA. Clinical implications of neuroscience research in PTSD. Ann N Y Acad Sci. 2006 Jul;1071:277-93. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinician Administered PTSD Scale (CAPS) | pre-intervention and 10 weeks | No | |
Secondary | PTSD Checklist Military Version (PCL-M) | pre-intervention, 5 weeks, 10 weeks and 3 months post intervention | No | |
Secondary | Impact of Events Scale - Revised (IES-R) | pre-intervention, 5 weeks, 10 weeks and 3 months post intervention | No | |
Secondary | 25-item Resilience Scale (RS) | pre-intervention, 5 weeks, 10 weeks and 3 months post intervention | No | |
Secondary | Twenty-four-hour urinary samples | pre-intervention and 3 months post intervention | No | |
Secondary | 10-minute segment of a seated 30-minute electrocardiogram recording session | pre-intervention and 3 months post intervention | No | |
Secondary | Beck Depression Inventory (BDI) | pre-intervention, 5 weeks, 10 weeks and 3 months post intervention | No | |
Secondary | Spielberger State Trait Anxiety Inventory (STAI) | pre-intervention, 5 weeks, 10 weeks and 3 months post intervention | No | |
Secondary | Daily Sleep Wake Diaries | during intervention (weeks 1-10) and 3 months post intervention | No | |
Secondary | Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) | pre-intervention, 5 weeks, 10 weeks and 3 months post intervention | No | |
Secondary | Credibility Expectancy Questionnaire (CEQ) | pre-intervention, 5 weeks, 10 weeks and 3 months post intervention | No | |
Secondary | Body-Oriented State Questionnaire (BOSC) | pre-intervention, 5 weeks, 10 weeks and 3 months post intervention | No | |
Secondary | 5-Facet Mindfulness Questionnaire (FFMQ) | pre-intervention, 5 weeks, 10 weeks and 3 months post intervention | No | |
Secondary | Perceived Stress Scale (PSS) | pre-intervention, 5 weeks, 10 weeks and 3 months post intervention | No | |
Secondary | Yoga Follow-up Questionnaire | 3 months post intervention | No | |
Secondary | PTSD Checklist Civilian Version (PCL-C) | pre-intervention, 5 weeks, 10 weeks and 3 months post intervention | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04317820 -
Deep Brain Reorienting in Post-traumatic Stress Disorder
|
N/A | |
Completed |
NCT05112003 -
Translingual Neurostimulation for the Virtual Treatment of Post-Traumatic Stress Disorder: A Feasibility Pilot
|
N/A | |
Recruiting |
NCT04518267 -
Anger and Psychotrauma: Data From Military and Civilians
|
||
Completed |
NCT02502604 -
Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder
|
N/A | |
Completed |
NCT02256566 -
Cognitive Training for Mood and Anxiety Disorders
|
N/A | |
Terminated |
NCT02234687 -
A mGlu2/3 Agonist in the Treatment of PTSD
|
Phase 1 | |
Terminated |
NCT02520726 -
PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims
|
Phase 4 | |
Completed |
NCT01738308 -
The Effects of Healing Touch on Post Operative Pediatric Patients
|
N/A | |
Completed |
NCT02213900 -
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
|
Phase 4 | |
Completed |
NCT01437891 -
Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF)
|
N/A | |
Completed |
NCT01517711 -
Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD)
|
Phase 4 | |
Completed |
NCT01199107 -
Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)
|
Phase 3 | |
Completed |
NCT01998100 -
Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
|
Phase 3 | |
Completed |
NCT01231711 -
Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based Intervention
|
Phase 1 | |
Completed |
NCT00680524 -
Telephone-based Care for OEF/OIF Veterans With PTSD
|
N/A | |
Completed |
NCT00838006 -
Psychophysiologic Predictors of Post-deployment Mental Health Outcomes
|
N/A | |
Completed |
NCT00348036 -
Group Intervention for Interpersonal Trauma
|
N/A | |
Completed |
NCT00525226 -
Evaluating the Effects of Stress in Pregnancy
|
N/A | |
Completed |
NCT00127673 -
Comparison of Two Treatments for Post-Traumatic Stress Disorder
|
Phase 3 | |
Completed |
NCT00158262 -
Effect of Propranolol on Preventing Posttraumatic Stress Disorder
|
Phase 4 |